Gene therapy lets teen dodge sickle cell disease – WDEF News 12
WDEF News 12 |
Gene therapy lets teen dodge sickle cell disease
WDEF News 12 (CBS News) – A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of the disorder, researchers report. The first-in-the-world case is detailed in … Sickle cell anemia patient ‘cured’ by gene therapy, doctors sayFOX 61 In a first, gene therapy cures teen with sickle cell diseaseEconomic Times Case Report: Sickle Cell Disease Gene TherapyRare Disease Report Japan Today –BioNews –BBC News –New England Journal of Medicine all 77 news articles » |
WDEF News 12 |
Gene therapy lets teen dodge sickle cell disease
WDEF News 12 (CBS News) – A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of the disorder, researchers report. The first-in-the-world case is detailed in … Sickle cell anemia patient ‘cured’ by gene therapy, doctors sayFOX 61 In a first, gene therapy cures teen with sickle cell diseaseEconomic Times Case Report: Sickle Cell Disease Gene TherapyRare Disease Report Japan Today –BioNews –BBC News –New England Journal of Medicine all 77 news articles » |
ScienceBlog.com (blog) |
Using Stem Cells to Predict Toxicity of Chemotherapy Drugs
ScienceBlog.com (blog) A team of scientists has developed a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for their potential to damage patients’ hearts. The study, published in Science Translational Medicine … |
Northwestern University NewsCenter |
Using Stem Cells to Predict Toxicity of Chemotherapy Drugs
Northwestern University NewsCenter A team of scientists has developed a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for their potential to damage patients’ hearts. The study, published in Science Translational Medicine … |
OncLive |
Ongoing Research of Immunotherapy in HNSCC
OncLive Ezra Cohen, MD: Without a doubt, immunotherapy has changed the landscape for patients with squamous cell carcinoma of the head and neck. We’ve seen approval of both nivolumab and pembrolizumab for patients with recurrent and metastatic disease. |